Shahid motahari hospital, Esfahan Esteel company, Iran
Isfahan, Iran
NCT Number: NCT01049321
The investigators are not aware of any study regarding the effect of DASH eating pattern on different cardiovascular risks among type 2 diabetic patients. The investigators assumed that DASH eating pattern could reduce the cardio-metabolic risks and improve the hepatic function among type 2 diabetes.
Looking for future studies?
Notify Me44 year–70 year
All sexes
Interventional
Phase 4
Isfahan, Iran
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Dietary aproaches to stop hypertension
Time frame: 6 months
Time frame: 6 months
Isfahan University of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02164578
Type 2 Diabetic Patients
Dresden, Saxony, Germany
View Trial DetailsNCT03006159
Type 2 Diabetic Patients
View Trial DetailsNCT01049750
Diabetes Mellitus, Diabetes Mellitus, Type 2
Pavia, Italy
View Trial DetailsNCT00941148
Insufficient Metabolic Control, OAD Treatment
Mainz, RLP, Germany
View Trial Details